Ocumetics reports 12-month follow-up for first-in-human Group One patients
Ocumetics says its first-in-human Group One clinical patients have reached their 12-month follow-up milestone.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.